Почетна › Urotelni (prelaznoćelijski) karcinom › Kalifornija › Los Angeles
Kliničke studije za Urotelni (prelaznoćelijski) karcinom u gradu Los Angeles, CA
17 studija za Urotelni (prelaznoćelijski) karcinom traži učesnike na lokacijama u gradu Los Angeles i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Тражи се учесникФаза 2
- Keck Medicine of USC Koreatown, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- USC / Norris Comprehensive Cancer Center, Los Angeles
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Тражи се учесникФаза 1/2
- California Research Institute, Los Angeles
- University of Southern California Norris Comprehensive Cancer Center, Los Angeles
- Valkyrie Clinical Trials, Los Angeles
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Тражи се учесникФаза 1
- Administrative Address: UCLA Hematology/Oncology, Los Angeles
- Ronald Reagan UCLA Medical Center, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Тражи се учесникФаза 1/2
- Los Angeles Cancer Network, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Тражи се учесникФаза 1
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
- и још 1
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Тражи се учесникФаза 1
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Тражи се учесникФаза 1/2
- START Los Angeles, LLC, Los Angeles
- Los Angeles Cancer Network - Century City, Los Angeles
- (IRB# 26-0433) Ronald Reagan UCLA Medical Center, Drug Information Center, Los Angeles
- и још 1
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Тражи се учесникФаза 3
- TRIO-US (Translational Research in Oncology-US), Los Angeles
- UCLA Hematology/Oncology - Santa Monica, Los Angeles
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Тражи се учесникФаза 1/2
- University of Southern California, Los Angeles
A Study of Ivonescimab in Combination With Enfortumab Vedotin vs Pembrolizumab in Combination With Enfortumab Vedotin in Metastatic Urothelial Carcinoma
Тражи се учесникФаза 2/3
- Research Site, Los Angeles
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Тражи се учесникФаза 2/3
- Research Site, Los Angeles
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Тражи се учесникФаза 1/2
- USC/Norris Comprehensive Cancer Center, Los Angeles
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Тражи се учесникФаза 2
- UCLA Downtown Los Angeles Primary & Specialty Care, Los Angeles
- Kaiser Permanente Los Angeles Medical Offices, Los Angeles
- Kaiser Permanente West Los Angeles Medical Center, Los Angeles
- и још 6
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Тражи се учесник
- Urology Group of Southern California, Los Angeles
- Comprehensive Urology, Los Angeles
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
Тражи се учесникФаза 1/2
- USC Norris Comprehensive Cancer Center, Los Angeles
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Тражи се учесникФаза 1/2
- University of Southern California, Los Angeles
A Study of NX-1607 in Adults With Advanced Malignancies
Тражи се учесникФаза 1
- University of Southern California, Los Angeles
Studije za Urotelni (prelaznoćelijski) karcinom u drugim gradovima
- Nashville, TN24 студија
- New York City, NY22 студија
- Houston, TX20 студија
- Edison, NJ18 студија
- Dallas, TX18 студија
- Queens, NY16 студија
- Chicago, IL14 студија
- Boston, MA13 студија
- Arlington, VA13 студија
- San Antonio, TX13 студија
- Austin, TX10 студија
- Orlando, FL10 студија
Ostale studije u gradu Los Angeles
- Немалоклетни карцином плућа92 студија
- Рак дојке73 студија
- Рак (све врсте)73 студија
- Рак простате64 студија
- Колоректални карцином61 студија
- Метастатски карцином57 студија
- Рак јајника53 студија
- Рак плућа45 студија
- Плоскоклеточни карцином главе и врата43 студија
- Рак панкреаса36 студија
- Карцином ендометријума35 студија
- Меланом34 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.